Heart Attack vs Cancer

The two deaths

"Financial services firms die from one of two causes. Heart attacks or cancer." The framework comes from Marc Rowan of Apollo Global Management, drawn from walking into Drexel Burnham Lambert on a Sunday in February 1990 and finding the firm gone.¹

A heart attack is funding risk: "If you lend long and borrow short, you have funding risk." It is sudden, total, and largely independent of asset quality, the kind of failure where a firm dies holding assets that are, in the main, still there. The failure sits on the liability side. Cancer is asset accumulation, "the addition of bad assets over a long period of time." It is slow, survivable for years, and usually invisible until the aggregate becomes fatal. The failure sits on the asset side, and specifically in the refusal to recognize it.

Why the split matters

The two failure modes require opposite defenses, which is the real value of the framework. A heart attack is a structural problem: by the time a run starts, the decision that killed the firm was made years earlier, so it can only be prevented by refusing duration mismatch as a matter of policy. A business built around matching long-dated liabilities to long-duration assets treats this as a heart-attack immunization first and a return strategy second.

Cancer is a behavioral problem with no structural fix, because the mechanism is human: the instinct to defend a position rather than mark it to reality. Rowan's stated antidote is cultural rather than structural: "we admit our mistakes. We move on. We take our losses. We don't double down and triple down and do these other things." His claim is that a firm investing its own capital metabolizes losses faster than one investing only other people's money.¹

The immunization as a business definition

Asked whether Apollo has effectively become a bank without deposits, Rowan gives a three-part answer that amounts to a list of heart-attack preconditions: "A bank works with a government guarantee, they take deposits, they do maturity transformation, and they primarily make money from the capacity of their own balance sheet. We do two or three different things. We don't take deposits, we don't have a government guarantee, but we originate investments and we distribute them."¹

The middle item is the one that matters: maturity transformation is the heart attack, stated as a mechanism rather than a metaphor. Borrow on demand, lend for years, and the gap is a run waiting for a trigger. A firm funded instead by long-dated retirement liabilities has no demand-callable funding to run on, which removes the failure mode structurally rather than managerially.

Convergence with Saylor

The same heart-attack mechanism appears, derived independently, in Michael Saylor's framework for capital duration. Saylor ranks financial instruments by how long capital realistically stays available before a covenant, margin call, or liquidation event can take it away, and names the same category of duration-mismatch failure, funding structures like Lehman Brothers and Long-Term Capital Management that borrowed short against long-duration positions, as the canonical death. The convergence is notable because it comes from opposite ends of finance: a hundred-trillion-dollar credit manager and a Bitcoin treasury operator arriving at the identical diagnosis through entirely different businesses.

What Rowan's framework adds that a pure duration ladder does not cover is that cancer has no duration at all. A firm can pass every duration test and still die slowly, because the instrument is fine and the asset underneath it is rotten.

Limits

Rowan states both preventions as settled facts about his own firm, which is a claim about intent and structure rather than independently verified evidence. The cancer defense in particular is unfalsifiable from outside, since a firm accumulating bad assets typically believes it is not. The heart-attack claim is the stronger of the two because it is structural and checkable in principle, but a claim of no maturity transformation describes the parent company and its insurance liabilities without necessarily covering redemption terms on more liquid vehicles sold to individual investors, where a gate is not technically a run but is the same underlying pressure arriving at a different door.